T J Dougherty. Show Affiliations »
Abstract
Mesh: See more » Antineoplastic Agents/administration & dosageCarcinoma in Situ/radiotherapyCarcinoma, Transitional Cell/radiotherapyClinical Trials as TopicHematoporphyrin DerivativeHematoporphyrins/administration & dosageHumansLung Neoplasms/radiotherapyRadiation-Sensitizing Agents/administration & dosageSkin Neoplasms/radiotherapyTime FactorsUrinary Bladder Neoplasms/radiotherapy
Substances: See more » Antineoplastic AgentsHematoporphyrinsRadiation-Sensitizing AgentsHematoporphyrin Derivative
Year: 1984 PMID: 6230788 DOI: 10.1016/s0090-4295(84)80119-3
Source DB: PubMed Journal: Urology ISSN: 0090-4295 Impact factor: 2.649